CCLD, US14167R1005

CareCloud says recurring revenue is 75.00 percent: CareCloud stock trades at USD 77.1 million value

Published on 10/20/2026 at 21:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CareCloud's adjusted EBITDA reached USD 5.90 million in the second quarter. CareCloud stock costs EUR 1.61 on October 20, 2026 in Germany.

Recurring revenue and dates

  • CareCloud said recurring solutions represented 75.00 percent of second-quarter revenue in the October 7, 2026 transcript.
  • Adjusted EBITDA reached USD 5.90 million in the second quarter of 2026.
  • CareCloud stock was at EUR 1.61 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST.
  • CareCloud will release third-quarter 2026 results on November 5, 2026.
CCLD, US14167R1005, Illustration mit AI erstellt.

CareCloud (ISIN US14167R1005) said recurring technology-enabled solutions represented 75.00 percent of revenue in the second quarter of 2026. In its October 7, 2026 earnings-call transcript, Benzinga reported that adjusted EBITDA reached USD 5.90 million. CareCloud stock was trading at EUR 1.61 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST.

Recurring revenue shapes the mix

The revenue mix is shifting toward subscription-based activity. CareCloud's recurring technology-enabled business solutions accounted for 75.00 percent of second-quarter revenue, compared with 69.00 percent in the year-earlier quarter, according to Benzinga. The same transcript said second-quarter revenue was USD 31.90 million, up 16.00 percent from USD 27.40 million a year earlier.

Stock position in dollars

CareCloud's Nasdaq quote was USD 1.81 on October 20, 2026 at 3:02 p.m. ET. The 52-week range was USD 1.73 to USD 3.81, placing the quote above the lower end of that band. Trading volume stood at 78,156 shares, while market capitalization was USD 77.1 million on the same date.

November 5 brings the next report

CareCloud will release its third-quarter 2026 results before the market opens on November 5, 2026, covering the period ended September 30, 2026. The company also scheduled an 8:30 a.m. ET conference call, as stated by GlobeNewswire on October 15, 2026.

What the next quarter must show

The upcoming report will provide a fresh test of whether the recurring revenue mix can support the company's stated growth plan. The second-quarter transcript also recorded adjusted EBITDA of USD 5.90 million and first-half revenue of USD 63.20 million, giving investors two operating measures to compare with the third-quarter release.

CareCloud stock stays in a wide range

CareCloud stock was trading at EUR 1.61 at Lang & Schwarz on October 20, 2026 at 9:01 p.m. CEST. The next scheduled results date is November 5, 2026.

The further course of trading is shown by the continuously updated real-time quote of CareCloud stock.

CareCloud stock facts

  • Company: CareCloud, Inc.
  • ISIN: US14167R1005
  • Ticker: CCLD
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 20, 2026, 9:01 p.m. CEST): EUR 1.61
  • Market capitalization: USD 77.1 million (as of October 20, 2026)
  • 52-week range: USD 1.73-3.81 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Information Services
  • Volume: 78,156 shares (as of October 20, 2026)

Market context: Market report Nasdaq Composite.

More news and analyses on CareCloud stock

Disclaimer...
en | US14167R1005 | CCLD | boerse | 70377738 |